00

Anhui Fengyuan Pharmaceutical Co LtdSHE 000153 Stock Report

Last reporting period 30 Sep, 2023

Updated 08 Nov, 2024

Last price

Market cap $B

0.355

Micro

Exchange

XSHE - Shenzhen Stock Exchange

000153.SZ Stock Analysis

00

Neutral

Based on Eyestock quantitative analysis, 000153.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

50/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

45.2 %

Greatly undervalued

Market cap $B

0.355

Dividend yield

3.23 %

Shares outstanding

332.11 B

Anhui Fengyuan Pharmaceutical Co., Ltd. engages in the pharmaceutical manufacturing and drug retail distribution business. The company is headquartered in Hefei, Anhui and currently employs 4,538 full-time employees. The company went IPO on 2000-09-20. The firm's products mainly include antipyretic and analgesic, women and children, the nervous system, cardiovascular, urinary system, nutrition, antibiotics and active ingredient and other products. The firm is also engaged in the retailing and wholesale of drugs. The firm conducts its businesses mainly in domestic markets, with Anhui province as its main market.

View Section: Eyestock Rating